Cargando…

Evaluation of Rosuvastatin Therapy on SIRT1 Gene Expression in Patients with Multiple Sclerosis: An Uncontrolled Clinical Trial

BACKGROUND: Multiple sclerosis (MS) is a chronic autoimmune disease. Current medications have some limitations such as low efficacy and high side effects. In recent years, statins have been raised as potential therapeutics for MS treatment with minimal complications. In addition, patient monitoring...

Descripción completa

Detalles Bibliográficos
Autores principales:	Batoee, Shakiba, Etminaniesfahani, Maryam, Mazdeh, Mehrdokht, Soltanian, Alireza, Nouri, Fatemeh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10630595/ https://www.ncbi.nlm.nih.gov/pubmed/38021265 http://dx.doi.org/10.1016/j.curtheres.2023.100718

Ejemplares similares

Effectiveness of Repetitive Transcranial Magnetic Stimulation (rTMS) Add-On Therapy to a Standard Treatment in Individuals with Multiple Sclerosis and Concomitant Symptoms of Depression—Results from a Randomized Clinical Trial and Pilot Study
por: Ahmadpanah, Mohammad, et al.
Publicado: (2023)

Efficacy of doxycycline as add-on to interferon beta-1a in treatment of multiple sclerosis
por: Mazdeh, Mehrdokht, et al.
Publicado: (2012)

A non-randomized clinical trial to evaluate the effect of fingolimod on expanded disability status scale score and number of relapses in relapsing-remitting multiple sclerosis patients
por: Mazdeh, Mehrdokht, et al.
Publicado: (2019)

Effect of progressive muscle relaxation technique on self-esteem and self-efficacy in multiple sclerosis patients: A clinical trial study
por: Akbari, Ali, et al.
Publicado: (2022)

The Effect of Continuous Care on the Lifestyle of Patients with Multiple Sclerosis: A Randomized Clinical Trial
por: Khodaveisi, Masoud, et al.
Publicado: (2017)

The effect of natalizumab on disability score and relapse rate of multiple sclerosis patients: a prospective cohort study
por: Mazdeh, Mehrdokht, et al.
Publicado: (2018)

Leisure time activities of Iranian patients with multiple sclerosis: a qualitative study
por: Hosseini, Seyed Mohammad Sadegh, et al.
Publicado: (2016)

Multiple Sclerosis Associated Risk Factors: A Case-Control Study
por: POOROLAJAL, Jalal, et al.
Publicado: (2015)

Clinical Evidence of Acetyl-L-Carnitine Efficacy in the Treatment of Acute Ischemic Stroke: A Pilot Clinical Trial
por: Mazdeh, Mehrdokht, et al.
Publicado: (2022)

Expression analysis of protein inhibitor of activated STAT (PIAS) genes in IFNβ-treated multiple sclerosis patients
por: Taheri, Mohammad, et al.
Publicado: (2018)

The Growth Arrest-Specific Transcript 5 (GAS5) and Nuclear Receptor Subfamily 3 Group C Member 1 (NR3C1): Novel Markers Involved in Multiple Sclerosis
por: Gharesouran, Jalal, et al.
Publicado: (2018)

Evidence for a Beneficial Effect of Oral N-acetylcysteine on Functional Outcomes and Inflammatory Biomarkers in Patients with Acute Ischemic Stroke
por: Sabetghadam, Maryam, et al.
Publicado: (2020)

Comparison of the Effect of Four Transcranial Direct Current Stimulation Configurations on Picture-Naming Improvement in Non-Fluent Aphasia: A Randomized Clinical Trial
por: Rezaei, Bahareh, et al.
Publicado: (2023)

The Relationship Between Salivary Alpha Amylase Activity and Score of McGill Pain Questionnaire in Patients With Tension Type Headache
por: Vahedi, Mohammad, et al.
Publicado: (2018)

Parkinson’s disease tremor prediction using EEG data analysis-A preliminary and feasibility study
por: Farashi, Sajjad, et al.
Publicado: (2023)

Comparison of administration of clopidogrel with aspirin versus aspirin alone in prevention of secondary stroke after transient ischemic attack
por: Khazaei, Mojtaba, et al.
Publicado: (2019)

Erasmus Syndrome: A Case Series of Rare Co-Occurrence of Silicosis and Systemic Sclerosis
por: Jaanakhi, V M, et al.
Publicado: (2022)

Experiences of persons with multiple sclerosis of a collaborative care programme: A qualitative study
por: Payamani, Firuzeh, et al.
Publicado: (2023)

Expression Analysis of NF-κB-Related lncRNAs in Parkinson’s Disease
por: Ghafouri-Fard, Soudeh, et al.
Publicado: (2021)

The role of SIRT1 level and SIRT1 gene polymorphisms in optic neuritis patients with multiple sclerosis
por: Kubiliute, Aleksandra, et al.
Publicado: (2023)

Demographic and Clinical Characteristics of Familial and Sporadic Multiple Sclerosis Patients
por: Mokhtari, Shahrzad, et al.
Publicado: (2023)

Current and Future Therapies for Multiple Sclerosis
por: Minagar, Alireza
Publicado: (2013)

The effect of applying the nursing process based on the Theory of Goal Attainment on activities of daily living and quality of life in persons with multiple sclerosis during COVID-19 pandemic: a clinical trial
por: Payamani, Firuzeh, et al.
Publicado: (2022)

Current Perspectives on rosuvastatin
por: Hu, Miao, et al.
Publicado: (2013)

Effects of rosuvastatin combined with fasudil therapy on rabbits with dyslipidemia
por: Li, Zhiming, et al.
Publicado: (2015)

Combination Therapy of Ezetimibe and Rosuvastatin for Dyslipidemia: Current Insights
por: Chilbert, Maya R, et al.
Publicado: (2022)

The effect of atorvastatin on the common carotid artery intima-media thickness in patients with ischemic stroke
por: Khazaei, Mojtaba, et al.
Publicado: (2020)

Role of SIRT1 Gene Polymorphisms and Serum Levels in Patients with Multiple Sclerosis
por: Kaikaryte, Kriste, et al.
Publicado: (2023)

Comparison of anti-inflammatory effects and high-density lipoprotein cholesterol levels between therapy with quadruple-dose rosuvastatin and rosuvastatin combined with ezetimibe
por: Yamazaki, Daisuke, et al.
Publicado: (2013)

Personalized rosuvastatin therapy in problem patients with partial statin intolerance
por: Shek, Aleksandr B., et al.
Publicado: (2018)

Month of Birth and the Incidence of Multiple Sclerosis in Southern Iran
por: Nikseresht, Alireza, et al.
Publicado: (2014)

Rosuvastatin and chronic hepatitis C
por: Yoshida, Eric M.
Publicado: (2011)

Rosuvastatin induced photolocalized purpura
por: Thabouti, Marwa, et al.
Publicado: (2022)

Comparison of the effect of rosuvastatin versus rosuvastatin/ezetimibe on markers of inflammation in patients with acute myocardial infarction
por: Ren, Yizhi, et al.
Publicado: (2017)

Evaluation of drug interactions between fimasartan and rosuvastatin after single and multiple doses in healthy Caucasians
por: Lee, Jieon, et al.
Publicado: (2018)

Remyelination therapy goes to trial for multiple sclerosis
por: Brugarolas, Pedro, et al.
Publicado: (2014)

Comparison of the Efficacy and Safety of Rosuvastatin/Ezetimibe Combination Therapy and Rosuvastatin Monotherapy on Lipoprotein in Patients With Type 2 Diabetes: Multicenter Randomized Controlled Study
por: Lee, Jiwoo, et al.
Publicado: (2020)

A Review of Herbal Therapy in Multiple Sclerosis
por: Mojaverrostami, Sina, et al.
Publicado: (2018)

An economic evaluation of rosuvastatin treatment in systolic heart failure: evidence from the CORONA trial
por: Lorgelly, Paula K., et al.
Publicado: (2010)

A clinical trial on the effect of a multifaceted intervention on blood pressure control and medication adherence in patients with uncontrolled hypertension
por: Mirniam, Azam-Alsadat, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_hn1956fke61h46a2ttlpmc47sp